Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era

Nature Reviews Urology, Published online: 17 December 2020; doi:10.1038/s41585-020-00419-zThe COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.

Source: Nature Reviews Urology - December 17, 2020 Category: Urology & Nephrology Authors: Kenrick Ng Krishna Vinnakota Anand Sharma John Kelly Prokar Dasgupta Nikhil Vasdev Source Type: research